H Watanabe, S Sato, N Maeda, Y Inoue, Y Shimomura, Y Tano. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdolescentCilastatin/therapeutic useCornea/drug effectsCornea/microbiologyCorneal Diseases/drug therapyCorneal Diseases/microbiologyCorneal Diseases/pathologyCorneal Transplantation/adverse effectsDrug Therapy, CombinationEye Infections, Bacterial/drug therapyEye Infections, Bacterial/etiologyEye Infections, Bacterial/pathologyHumansImipenem/therapeutic useInjections, IntravenousLaser Therapy/adverse effectsMaleOfloxacin/therapeutic useOintmentsOphthalmic SolutionsProtease Inhibitors/therapeutic useStaphylococcal Infections/drug therapyStaphylococcal Infections/etiologyStaphylococcal Infections/pathologyStaphylococcus aureus/isolation & purification
Substances： See more » OintmentsOphthalmic SolutionsProtease InhibitorsCilastatinImipenemOfloxacin
Year: 1997 PMID： 9400799 DOI： 10.1001/archopht.1997.01100160763019
Source DB: PubMed Journal: Arch Ophthalmol ISSN： 0003-9950